{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:24:00Z","timestamp":1791649440353,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10072-025-08246-z","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:55:23Z","timestamp":1748472923000},"page":"4181-4192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dopa-responsive dystonia and phenotypes associated with TH gene variants: a systematic review and Mexican case series"],"prefix":"10.1007","volume":"46","author":[{"given":"Carlos Ulises","family":"Lopez-Urias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Monroy-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Barreda Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-3636","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Ram\u00edrez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"7","key":"8246_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Jankovic J (2015) Dopa-responsive dystonia\u2014clinical and genetic heterogeneity. Nat Rev Neurol 11(7):414\u2013424. https:\/\/doi.org\/10.1038\/nrneurol.2015.86","journal-title":"Nat Rev Neurol"},{"key":"8246_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/B978-0-444-52014-2.00039-2","volume":"100","author":"M Segawa","year":"2011","unstructured":"Segawa M (2011) Dopa-responsive dystonia. Handb Clin Neurol 100:539\u2013557. https:\/\/doi.org\/10.1016\/B978-0-444-52014-2.00039-2","journal-title":"Handb Clin Neurol"},{"key":"8246_CR3","doi-asserted-by":"publisher","unstructured":"Lee WW, Jeon BS (2014) Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep 14(7). https:\/\/doi.org\/10.1007\/s11910-014-0461-9","DOI":"10.1007\/s11910-014-0461-9"},{"key":"8246_CR4","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Alvarez E, Nardocci (2012) Update on pediatric dystonias: etiology, epidemiology, and management. Degener Neurol Neuromuscul Dis 29. https:\/\/doi.org\/10.2147\/DNND.S16082","DOI":"10.2147\/DNND.S16082"},{"key":"8246_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2017.09.017","volume":"45","author":"V Dobri\u010di\u0107","year":"2017","unstructured":"Dobri\u010di\u0107 V, Tomi\u0107 A, Brankovi\u0107 V, Kresojevi\u0107 N, Jankovi\u0107 M, Westenberger A et al (2017) GCH1 mutations are common in Serbian patients with dystonia parkinsonism: Challenging previously reported prevalence rates of DOPA responsive dystonia. Park Relat Disord 45:81\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.09.017","journal-title":"Park Relat Disord"},{"issue":"11","key":"8246_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/jpm11111186","volume":"11","author":"G Nygaard","year":"2021","unstructured":"Nygaard G, Szigetvari PD, Grindheim AK, Ruoff P, Martinez A, Haavik J et al (2021) Personalized medicine to improve treatment of dopa-responsive dystonia\u2014a focus on tyrosine hydroxylase deficiency. J Pers Med. 11(11):1186. https:\/\/doi.org\/10.3390\/jpm11111186","journal-title":"J Pers Med."},{"key":"8246_CR7","unstructured":"Furukawa Y, Kish S. Tyrosine Hydroxylase Deficiency. 2008 Feb 8 [Updated 2017 May 11]. In: Adam MP, Feldman J, Mirzaa GM, et al (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle 1993\u20132024."},{"key":"8246_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2020.01.017","volume":"71","author":"JF Bally","year":"2020","unstructured":"Bally JF, Breen DP, Schaake S et al (2020) Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency? Parkinsonism Relat Disord 71:44\u201345. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.01.017","journal-title":"Parkinsonism Relat Disord"},{"issue":"33","key":"8246_CR9","doi-asserted-by":"publisher","first-page":"e21753","DOI":"10.1097\/MD.0000000000021753","volume":"99","author":"H-Y Dong","year":"2020","unstructured":"Dong H-Y, Feng J-Y, Yue X-J, Shan L, Jia F-Y (2020) Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Med (Baltimore) 99(33):e21753. https:\/\/doi.org\/10.1097\/MD.0000000000021753","journal-title":"Med (Baltimore)"},{"issue":"8","key":"8246_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/mds.23564","volume":"26","author":"A Ormazabal","year":"2011","unstructured":"Ormazabal A, Serrano M, Garcia-Cazorla A et al (2011) Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype. Mov Disord 26(8):1558\u20131560. https:\/\/doi.org\/10.1002\/mds.23564","journal-title":"Mov Disord"},{"key":"8246_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jmd2.12111","volume":"53","author":"S Bijarnia-Mahay","year":"2020","unstructured":"Bijarnia-Mahay S, Jain V, Th\u00f6ny B (2020) Tyrosine hydroxylase deficiency\u2014Clinical insights and a novel deletion in TH gene in an Indian patient. JIMD Reports 53:12\u201315. https:\/\/doi.org\/10.1002\/jmd2.12111","journal-title":"JIMD Reports"},{"issue":"9","key":"8246_CR12","doi-asserted-by":"publisher","first-page":"e106388","DOI":"10.1371\/journal.pone.0106388","volume":"9","author":"Z-f Sun","year":"2014","unstructured":"Sun Z-f, Zhang Y-h, Guo J-f, Sun Q-y, Mei J-p et al (2014) Genetic diagnosis of two dopa-responsive dystonia families by exome sequencing. PLoS ONE 9(9):e106388. https:\/\/doi.org\/10.1371\/journal.pone.0106388","journal-title":"PLoS ONE"},{"key":"8246_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1371\/journal.pmed.1000097","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, P Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 151:264\u20139. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"Ann Intern Med."},{"issue":"2","key":"8246_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/WNL.56.2.260","volume":"56","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ (2001) Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56(2):260\u2013263. https:\/\/doi.org\/10.1212\/WNL.56.2.260","journal-title":"Neurology"},{"issue":"6","key":"8246_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13312-017-1055-9","volume":"54","author":"JN Goswami","year":"2017","unstructured":"Goswami JN, Sankhyan N, Singhi PD (2017) An Indian Family with Tyrosine Hydroxylase Deficiency. Indian Pediatr 54(6):499\u2013501. https:\/\/doi.org\/10.1007\/s13312-017-1055-9","journal-title":"Indian Pediatr"},{"key":"8246_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fped.2020.00083","volume":"8","author":"Y Chen","year":"2020","unstructured":"Chen Y, Bao X, Wen Y, Wang J, Zhang Q, Yan J (2020) Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia. Front Pediatr 8:83. https:\/\/doi.org\/10.3389\/fped.2020.00083","journal-title":"Front Pediatr"},{"key":"8246_CR17","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1016\/S1353-8020(13)70033-6","volume":"20","author":"C Klein","year":"2014","unstructured":"Klein C (2014) Genetics in dystonia. Parkinsonism Relat Disord 20:S137\u2013S142. https:\/\/doi.org\/10.1016\/S1353-8020(13)70033-6","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"8246_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.28874","volume":"37","author":"A Weissbach","year":"2022","unstructured":"Weissbach A, Pauly MG, Herzog R, Hahn L, Halmans S, Hamami F et al (2022) Relationship of genotype, phenotype, and treatment in dopa-responsive dystonia: MDSGene review. Mov Disord 37(2):237\u2013252. https:\/\/doi.org\/10.1002\/mds.28874","journal-title":"Mov Disord"},{"key":"8246_CR19","doi-asserted-by":"publisher","unstructured":"Bittles AH, Black ML (2010) Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A 107 Suppl 1(Suppl 1):1779\u201386. https:\/\/doi.org\/10.1073\/pnas.0906079106","DOI":"10.1073\/pnas.0906079106"},{"issue":"28","key":"8246_CR20","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.3346\/jkms.2018.33.e184","volume":"33","author":"WW Lee","year":"2018","unstructured":"Lee WW, Jeon B, Kim R (2018) Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike. J Korean Med Sci 33(28):e184. https:\/\/doi.org\/10.3346\/jkms.2018.33.e184","journal-title":"J Korean Med Sci"},{"issue":"Pt 6","key":"8246_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/brain\/awq087","volume":"133","author":"MA Willemsen","year":"2010","unstructured":"Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N et al (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133(Pt 6):1810\u20131822. https:\/\/doi.org\/10.1093\/brain\/awq087","journal-title":"Brain"},{"key":"8246_CR22","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1016\/S2214-109X(24)00056-1","volume":"12","author":"TLG Health","year":"2024","unstructured":"Health TLG (2024) The landscape for rare diseases in 2024. Lancet Global Health 12:e341. https:\/\/doi.org\/10.1016\/S2214-109X(24)00056-1","journal-title":"Lancet Global Health"},{"key":"8246_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.11.012","volume":"36","author":"E Barow","year":"2017","unstructured":"Barow E, Schneider SA, Bhatia KP, Ganos C (2017) Oculogyric crises: etiology, pathophysiology and therapeutic approaches. Park Relat Disord 36:3\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.012","journal-title":"Park Relat Disord"},{"key":"8246_CR24","unstructured":"Klein C, Lohmann K, Marras C, et al. Hereditary Dystonia Overview. 2003 Oct 28 [Updated 2017 Jun 22]. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle 1993\u20132024."},{"issue":"Suppl 1","key":"8246_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1468-1331.2010.03049.x","volume":"17","author":"F Asmus","year":"2010","unstructured":"Asmus F, Gasser T (2010) Dystonia-plus syndromes. Eur J Neurol 17(Suppl 1):37\u201345. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03049.x","journal-title":"Eur J Neurol"},{"key":"8246_CR26","doi-asserted-by":"publisher","first-page":"1004307","DOI":"10.3389\/fgene.2022.1004307","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang C, Liu M, Xu W, Wang S, Yuan F, Luo X, Xu Q, Yin R, Wang A, Guo M, Lin L, Wang C, Cheng H, Liu Z, Zhang Y, Zeng F, Yan J, Chen Y (2022) Segawa syndrome caused by TH gene mutation and its mechanism. Front Genet 13:1004307. https:\/\/doi.org\/10.3389\/fgene.2022.1004307","journal-title":"Front Genet"},{"key":"8246_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1212\/WNL.41.2_Part_1.174","volume":"41","author":"TG Nygaard","year":"1991","unstructured":"Nygaard TG, Marsden CD, Fahn S (1991) Dopa responsive dystonia: long-term treatment response and prognosis. Neurology 41:174\u2013181. https:\/\/doi.org\/10.1212\/WNL.41.2_Part_1.174","journal-title":"Neurology"},{"issue":"8","key":"8246_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1023\/A:1026760602577","volume":"23","author":"P De Lonlay","year":"2000","unstructured":"De Lonlay P, Nassogne MC, van Gennip AH et al (2000) Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation. J Inherit Metab Dis 23(8):819\u2013825. https:\/\/doi.org\/10.1023\/A:1026760602577","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"8246_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2009.02.001","volume":"97","author":"DI Zafeiriou","year":"2009","unstructured":"Zafeiriou DI, Willemsen MA, Verbeek MM, Vargiami E, Ververi A, Wevers R (2009) Tyrosine hydroxylase deficiency with severe clinical course. Mol Genet Metab 97(1):18\u201320. https:\/\/doi.org\/10.1016\/j.ymgme.2009.02.001","journal-title":"Mol Genet Metab"},{"issue":"Suppl 6","key":"8246_CR30","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1002\/ana.10632","volume":"54","author":"GF Hoffmann","year":"2003","unstructured":"Hoffmann GF, Assmann B, Br\u00e4utigam C et al (2003) Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 54(Suppl 6):S56-65. https:\/\/doi.org\/10.1002\/ana.10632","journal-title":"Ann Neurol"},{"issue":"2","key":"8246_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0883073810377014","volume":"26","author":"W-L Yeung","year":"2011","unstructured":"Yeung W-L, Wong VCN, Chan K-Y et al (2011) Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency. J Child Neurol 26(2):179\u2013187. https:\/\/doi.org\/10.1177\/0883073810377014","journal-title":"J Child Neurol"},{"issue":"5","key":"8246_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/mdc3.12361","volume":"3","author":"R Kim","year":"2016","unstructured":"Kim R, Jeon B, Lee WW (2016) A systematic review of treatment outcome in patients with dopa-responsive dystonia (DRD) and DRD-plus. Mov Disord Clin Pract 3(5):435\u2013442. https:\/\/doi.org\/10.1002\/mdc3.12361","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"8246_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/WNL.000000000000353","volume":"88","author":"V Leuzzi","year":"2017","unstructured":"Leuzzi V, Mastrangelo M, Giannini MT, Carbonetti R, Hofmann GF (2017) Neuromotor and cognitive outcomes of early treatment in tyrosine hydroxylase deficiency type B. Neurology 88(5):501\u2013502. https:\/\/doi.org\/10.1212\/WNL.000000000000353","journal-title":"Neurology"},{"key":"8246_CR34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s12031-02201992-1","volume":"72","author":"K Wang","year":"2022","unstructured":"Wang K, Zhang H, Ji J, Zhang R, Dang W, Xie Q et al (2022) Expression quantitative trait locus rs6356 is associated with susceptibility to heroin addiction by potentially influencing TH gene expression in the Hippocampus and nucleus Accumbens. J Mol Neurosci 72:1108\u20131115. https:\/\/doi.org\/10.1007\/s12031-02201992-1","journal-title":"J Mol Neurosci"},{"key":"8246_CR35","doi-asserted-by":"publisher","unstructured":"Yao T (2023) Functional Genomic Study of Tyrosine Hydroxylase rs6356 for Chronic Pain in Sickle Cell Disease. University of Illinois Chicago. Thesis. https:\/\/doi.org\/10.25417\/uic.23661126.v1","DOI":"10.25417\/uic.23661126.v1"},{"key":"8246_CR36","doi-asserted-by":"publisher","first-page":"644910","DOI":"10.3389\/fneur.2021.644910","volume":"12","author":"X-y Li","year":"2021","unstructured":"Li X-y, Yang Y-m, Li L-b, Zhang M-y, Huang Y-y, Wang J, Wang L, Wan X-h (2021) Identification of TH Variants in Chinese Dopa-Responsive Dystonia Patients and Long-Term Outcomes. Front Neurol 12:644910. https:\/\/doi.org\/10.3389\/fneur.2021.644910","journal-title":"Front Neurol"},{"key":"8246_CR37","first-page":"53","volume-title":"The metabolic and molecular bases of inherited disease","author":"AL Beaudet","year":"1995","unstructured":"Beaudet AL, Scriver CR, Sly WS, Valle D (1995) Genetics, biochemistry, and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 53\u2013118","edition":"7"},{"issue":"2","key":"8246_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.67020443.x","volume":"67","author":"SC Kumer","year":"1996","unstructured":"Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67(2):443\u2013462. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.67020443.x","journal-title":"J Neurochem"},{"issue":"5","key":"8246_CR39","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1038\/ncomms6769","volume":"10","author":"K Banerjee","year":"2014","unstructured":"Banerjee K, Wang M, Cai E, Fujiwara N, Baker H, Cave JW (2014) Regulation of tyrosine hydroxylase transcription by hnRNP K and DNA secondary structure. Nat Commun 10(5):5769. https:\/\/doi.org\/10.1038\/ncomms6769","journal-title":"Nat Commun"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08246-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08246-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:56:32Z","timestamp":1756364192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08246-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["8246"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08246-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research and Ethics Committees of the Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez (registration numbers: INNNMVS_155\/18 and INNNMVS_74\/21). All subjects were informed of the content of this study, and written informed consent was obtained.\u00a0All procedures performed in studies involving human participants have been conducted following the most recent version of the Declaration of Helsinki and its subsequent amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Patients included in this study provided informed consent to publish anonymized data following the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}